This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

President Donald Trump’s tariffs have two primary objectives. One is to rebalance the world trade order, which he believes is ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and since then has become widely used in economics, engineering, business and ...

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

CNBC's Jim Cramer on Friday walked investors through another busy week in the thick of earnings season. He highlighted reports from tech titans Apple, Amazon, Microsoft and Meta as well as the release ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...

Eli Lilly has lined up another deal in the radiopharmaceutical sector, paying $140 million to partner drugs developed by Radionetics Oncology and taking an option on buying the company outright ...

Roundup of Friday's high school sports action from the Greater Spokane League. Softball GSL 4A/3A Ridgeline 18, Central Valley 2 (5): Lilly Triplett went 4 for 5 with a home run, double, six RBIs and ...